{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:51:32Z","timestamp":1778860292633,"version":"3.51.4"},"reference-count":55,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"crossref","award":["GZ-2013-11007"],"award-info":[{"award-number":["GZ-2013-11007"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>The goal was to find if changes in Fabry keratopathy were clinically observable over time. Also observed were variations of Fabry keratopathy, supplemental features, unique presentations and differences between keratopathies of right and left corneas and the same family and genotype.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Biomicroscopic images of Fabry keratopathy in 10 persons with classic Fabry disease, 5 men and 5 women, were captured over an 18-month period. The keratopathies were categorised and scrutinised for changes over time, and differences between corneas of the same individual, family and genotype.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fabry keratopathy ranged from mild change to marked change over 18 months. There was a great variety of whorl patterns. A few keratopathies were amorphous without vortices and many vortices were supplemented with amorphous features. All keratopathies were accompanied by diffuse epithelial haze. There was a range from negligible difference to marked difference between right and left eyes of the same individuals with similarities appearing as imprecise mirror images of each other. In some corneas, prominent vertical streams from the superior limbus integrated into the primary keratopathy. Comparisons between persons with the same family and genotype were obscured by gender and differences between right and left eyes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Practitioners should be better able to detect Fabry disease having a fuller understanding of the variety of presentations of the dynamic, pathognomonic Fabry keratopathy. Routes of continuous centripetal renewal of corneal epithelium are spatially unique to each eye, in some cases subsidised by direct contribution of basal cells streamed from the superior limbus.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2019-314906","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T21:15:17Z","timestamp":1572470117000},"page":"1148-1155","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Fabry keratopathy: manifestations and changes over time"],"prefix":"10.1136","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-6115","authenticated-orcid":false,"given":"Melanie D","family":"Sivley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"2020080315452622000_104.8.1148.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.113.000249"},{"key":"2020080315452622000_104.8.1148.2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10157-017-1525-3","article-title":"Plasma lyso-Gb3: a biomarker for monitoring Fabry patients during enzyme replacement therapy","volume":"22","author":"Sakuraba","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"2020080315452622000_104.8.1148.3","unstructured":"Desnick R , Ioannou Y , Eng C . Alpha-galactosidase A deficiency: Fabry disease. In: Scriver CBA , Sly W , Valie D , eds. The metabolic bases of inherited disease . 8th edn. New York: McGraw-Hill, 20: 3733\u201374."},{"key":"2020080315452622000_104.8.1148.4","doi-asserted-by":"crossref","unstructured":"Mastropasqua L , Nubile M , Lanzini M , et al . Corneal and conjunctival manifestations in Fabry disease: in vivo confocal microscopy study. Am J Ophthalmol 2006;141:709.doi:10.1016\/j.ajo.2005.11.053","DOI":"10.1016\/j.ajo.2005.11.053"},{"key":"2020080315452622000_104.8.1148.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0962-9"},{"key":"2020080315452622000_104.8.1148.6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00417-011-1726-5","article-title":"Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy","volume":"249","author":"Wasielica-Poslednik","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2020080315452622000_104.8.1148.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0521-2"},{"key":"2020080315452622000_104.8.1148.8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.100602"},{"key":"2020080315452622000_104.8.1148.9","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/OPX.0b013e31827ec7eb","article-title":"Fabry disease: a review of ophthalmic and systemic manifestations","volume":"90","author":"Sivley","year":"2013","journal-title":"Optom Vis Sci"},{"key":"2020080315452622000_104.8.1148.10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF02229811","article-title":"Uber eine eigenartige bisher nicht bekannte Hornhauttrubung","volume":"77","author":"Fleischer","year":"1910","journal-title":"Graefes Arch Ophthalmol"},{"key":"2020080315452622000_104.8.1148.11","doi-asserted-by":"crossref","unstructured":"Weicksel J . Angiokeratosis bzw Angiokeratosis universalis (eine sehr seltene Haut-und Gefasserkrankung) Deutsch Med Wschr 1925;51:898\u2013900.","DOI":"10.1055\/s-0028-1136780"},{"key":"2020080315452622000_104.8.1148.12","unstructured":"Sodi A , Ioannidis A , Pitz S . Chapter 26: Ophthalmological manifestations of Fabry disease. In: Mehta A , Beck M , Sunder-Plassmann G , eds. Fabry disease: perspectives from 5 years of FOS . Oxford UK: Oxford Pharmagenesis, 2006: 26."},{"key":"2020080315452622000_104.8.1148.13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000300313","article-title":"Cornea verticillata. Eine enfach-dominante Variante Der Hornhaut des meschlichen Auges. 1. Mitteilung","volume":"111","author":"Gruber","year":"1946","journal-title":"Ophthalmologica"},{"key":"2020080315452622000_104.8.1148.14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000300370","article-title":"Cornea verticillata. 2. Mitteilung","volume":"112","author":"Gruber","year":"1946","journal-title":"Ophthalmologica"},{"key":"2020080315452622000_104.8.1148.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5082.1266"},{"key":"2020080315452622000_104.8.1148.16","first-page":"177","article-title":"Angiokeratoma corporis diffusum. A clinical study of eight affected families","volume":"31","author":"Wise","year":"1962","journal-title":"Q J Med"},{"key":"2020080315452622000_104.8.1148.17","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1965.00970040762005"},{"key":"2020080315452622000_104.8.1148.18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000305429","article-title":"La cornea verticillata (Gruber) et Ses relations avec La Maladie de Fabry (angiokeratoma corporis diffusum)","volume":"156","author":"Th.Franceschetti","year":"1968","journal-title":"Ophthalmologica"},{"key":"2020080315452622000_104.8.1148.19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000253987","article-title":"A study of Fabry's disease. I. clinical examination of a family with cornea verticillata","volume":"138","author":"Franceschetti","year":"1969","journal-title":"Dermatologica"},{"key":"2020080315452622000_104.8.1148.20","unstructured":"Franceschetti AT . Etude Ophtalmologique, Genetique et Biochimique de La Maladie de Fabry. These No. 3346, Universite de Geneve, Department des Specialites Medicales, Clinique D\u2019Ophtalmologie 1973."},{"key":"2020080315452622000_104.8.1148.21","first-page":"195","article-title":"Fabry disease: ocular manifestations","volume":"12","author":"Franceschetti","year":"1976","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2020080315452622000_104.8.1148.22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.survophthal.2008.04.005","article-title":"Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder","volume":"53","author":"Samiy","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"2020080315452622000_104.8.1148.23","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1979.01020010327008"},{"key":"2020080315452622000_104.8.1148.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2005.00990.x"},{"key":"2020080315452622000_104.8.1148.25","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-310088"},{"key":"2020080315452622000_104.8.1148.26","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306433"},{"key":"2020080315452622000_104.8.1148.27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1755-3768.1984.tb08444.x","article-title":"Corneal findings in a foetus with Fabry's disease","volume":"62","author":"Tsutsumi","year":"1984","journal-title":"Acta Ophthalmol"},{"key":"2020080315452622000_104.8.1148.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0196-0"},{"key":"2020080315452622000_104.8.1148.29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12886-016-0374-2","article-title":"Paediatric Fabry disease: prognostic significance of ocular changes for disease severity","volume":"16","author":"Kalkum","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"2020080315452622000_104.8.1148.30","doi-asserted-by":"crossref","unstructured":"Pitz S , Kalkum G , Arash L , et al . Ocular signs correlate well with disease severity and genotype in Fabry disease. PLoS One 2015;10:e0120814.doi:10.1371\/journal.pone.0120814","DOI":"10.1371\/journal.pone.0120814"},{"key":"2020080315452622000_104.8.1148.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.365"},{"key":"2020080315452622000_104.8.1148.32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00675.x"},{"key":"2020080315452622000_104.8.1148.33","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-104178"},{"key":"2020080315452622000_104.8.1148.34","first-page":"1962","article-title":"Kinetics of corneal epithelial maintenance and graft loss","volume":"30","author":"Sharma","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020080315452622000_104.8.1148.35","unstructured":"Oyster C . The cornea and the sclera. in: Oyster C. the human eye: structure and function . Sinauer Associates: Sunderland MA, 1999: 325\u201378."},{"key":"2020080315452622000_104.8.1148.36","doi-asserted-by":"crossref","unstructured":"Ikegawa Y , Shiraishi A , Hayashi Y , et al . In Vivo Confocal Microscopic Observations of Vortex Keratopathy in Patients with Amiodarone-Induced Keratopathy and Fabry Disease. J Ophthalmol 2018; ID 5315137:1\u20137.doi:10.1155\/2018\/5315137","DOI":"10.1155\/2018\/5315137"},{"key":"2020080315452622000_104.8.1148.37","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000378"},{"key":"2020080315452622000_104.8.1148.38","first-page":"75","article-title":"The structure of corpuscular nerve endings in the limbal conjunctiva of the human eye","volume":"177","author":"Lawrenson","year":"1991","journal-title":"J Anat"},{"key":"2020080315452622000_104.8.1148.39","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90958-6"},{"key":"2020080315452622000_104.8.1148.40","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1989.22"},{"key":"2020080315452622000_104.8.1148.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(00)00109-0"},{"key":"2020080315452622000_104.8.1148.42","doi-asserted-by":"publisher","DOI":"10.1038\/229560a0"},{"key":"2020080315452622000_104.8.1148.43","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0705"},{"key":"2020080315452622000_104.8.1148.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(02)02399-1"},{"key":"2020080315452622000_104.8.1148.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(03)00033-3"},{"key":"2020080315452622000_104.8.1148.46","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1423"},{"key":"2020080315452622000_104.8.1148.47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.preteyeres.2015.04.002","article-title":"Moving epithelia: tracking the fate of mammalian limbal epithelial stem cells","volume":"48","author":"Di Girolamo","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"2020080315452622000_104.8.1148.48","unstructured":"Prokopich CL , Bartlett JD , Jaanus SD . Ocular adverse drug reactions to systemic medications. In: Bartlett JD , Jaanus SD , eds. Clinical ocular pharmacology . 5 edn. St. Louis: Butterworth Heinemann\/Elsevier, 2008: 701\u201359."},{"key":"2020080315452622000_104.8.1148.49","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200208154"},{"key":"2020080315452622000_104.8.1148.50","doi-asserted-by":"publisher","DOI":"10.1038\/nature01006"},{"key":"2020080315452622000_104.8.1148.51","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3"},{"key":"2020080315452622000_104.8.1148.52","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.643"},{"key":"2020080315452622000_104.8.1148.53","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(99)00004-X"},{"key":"2020080315452622000_104.8.1148.54","doi-asserted-by":"crossref","unstructured":"Mali J , Morier A . Commentary: effect of agalsidase beta on corneal verticillata in patients with Fabry disease. J Clin Exp Ophthalmol 2016;7:530.doi:10.4172\/2155-9570.1000528","DOI":"10.4172\/2155-9570.1000528"},{"key":"2020080315452622000_104.8.1148.55","doi-asserted-by":"publisher","DOI":"10.1076\/opge.24.3.129.15609"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2019-314906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:01:39Z","timestamp":1601110899000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2019-314906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,7,23]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/bjophthalmol-2019-314906"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314906","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]}}}